---
category: news
title: "Lantern Pharma Reports Third Quarter 2020 Financial Results & Continued Operational Progress"
excerpt: "PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary artificial intelligence (\"A.I.\") platform, RADRÂ® , to transform oncology drug discovery and development,"
publishedDateTime: 2020-11-01T03:25:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-reports-third-quarter-2020-financial-results-continued-operational-progress-1029743641"
webUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-reports-third-quarter-2020-financial-results-continued-operational-progress-1029743641"
type: article
quality: 43
heat: 43
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg"
    width: 400
    height: 296
    isCached: true

secured: "DIl6VYlYkjB+P95F5Efe+nKXlamr19vxHfcSsRrgRTFgiytaYZApB5kXp0WjnhCfsrk2+cdmUT/0nFbP1UAyhwfcgqZkWSEszZ6nGKz4GXiaoaJD1z1A65Q5gE8a5cCs/6/n89AfYRDv/U91wBvV6jNS8ydhpKWJEwB9uuKf84+eTefEbIWvozCODqfLe/jaZ+k4Lly5dtVTzFQsUdE456v8/pZEh1HAIz8OP9DslSWX/9JtPbv0fy+3D/7syhwFuNywRQriTHxPa926SgoXG2jmA3e4v+2jTy2DwQxUeD66yPw6a73lGkjaYZWUb6pgXZaUshZTQTTStQKJQXI3tt8TgTlKFBEj4ldr09t/5D0=;Qz23Pn3llCmV96cCWsGBdg=="
---

